Mercia Ventures

Mercia Ventures, headquartered in Henley-in-Arden, is one of the United Kingdom’s most active regional venture managers, with offices across the Midlands, the North, and beyond. The firm operates as the venture arm of Mercia Asset Management, a publicly listed asset manager, and brings together equity venture capital, venture debt, and regional fund management mandates to support scaling UK healthcare and technology businesses outside of London.

The healthcare thesis spans digital health, biotech, and health IT, with active investment across both early-stage and growth opportunities. The firm is comfortable with technical risk in life sciences and biotech as well as commercial risk in software and digital health, supported by AI-enabled tooling. Mercia’s broader portfolio across enterprise software, consumer, and industrial provides cross-sector pattern recognition that informs its healthcare bets, particularly in categories where data infrastructure and workflow software intersect with clinical operations.

Mercia invests at Seed, Series A, and Series B with check sizes of $1M to $5M. Geographic focus is the United Kingdom, with deliberate emphasis on companies headquartered outside London, particularly in the Midlands, the North, and regional research clusters. The firm operates several regional funds in partnership with the British Business Bank, allowing it to deploy capital efficiently into companies that fit specific regional development mandates alongside its core EIS and institutional funds.

The team is large by UK regional standards, with investment professionals distributed across multiple offices and backgrounds spanning venture investing, banking, and operating roles. This distributed footprint gives the firm unusual deal flow into companies emerging from regional research universities, accelerators, and corporate spinouts, and supports a hands-on relationship with portfolio companies that may be hours from London by train.

Mercia’s working approach blends institutional discipline with regional accessibility. Portfolio founders describe partners who show up consistently, engage substantively on commercial and financial strategy, and bring introductions across the broader UK technology ecosystem and into key European corridors. The combination of equity and debt capabilities is unusually relevant for healthcare founders, who often face capital intensity around clinical trials, hardware development, and infrastructure build-out where structured debt can extend runway efficiently. Reporting expectations are formal and aligned with institutional venture norms, with quarterly board engagement and clear milestone tracking. Mercia will not be the right fit for founders looking exclusively for marquee London-name venture capital, but for UK healthcare and technology founders building outside the M25 corridor, the firm represents one of the most consistent, well-resourced, and accessible regional venture partners currently operating, with a track record of supporting companies from seed through commercial scale and the ability to flex capital structure to match the realities of healthcare and deep tech development cycles.